EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio Partnering Forum ChinaBio Group EBD Group ChinaBio Partnering Forum
Share/Follow Us
Share this:
Follow this event:

ChinaBio® Partnering Forum Press Releases

May 9, 2016ChinaBio® Partnering Forum 2016 in Suzhou, China is key entry point to global biopharma cross-border partnerships Suzhou, China will host the 8th annual ChinaBio® Partnering Forum 2016 life science partnering event May 18–19. China is the #2 pharmaceutical market and is still growing at 9–15% per year, according to a recent ChinaBio® Group report. As well, over USD 130 billion per year is invested in the China life science industry, with government investment up by ...  more ►

March 14, 2016ChinaBio® Partnering Forum 2016 returning to Suzhou, China's life science hub, May 18–19, 2016 The 8th annual ChinaBio® Partnering Forum 2016 life science partnering event will return to Suzhou, China, May 18–19. Suzhou is an active biopharma hub and the home of international and China pharmaceutical and medical companies, specializing in drug discovery, diagnostics, and medical devices. China is now the world's second largest and fastest growing major pharma market a...  more ►

June 11, 2015Spotlight on Suzhou Business Facts Population Suzhou, in China's Jiangsu Province, has a population of more than 5 million inhabitants and had a growth rate in excess of 6 percent per year between 2000 and 2014, according to 2014 UN data. BioBay innovation cluster BioBay, located in the Dushu Lake Science and Education Innovation District in Suzhou, is an innovative science and technology carrier for developmen...  more ►

partnering360® Blog

June 21, 2016 Single-use technology means big cost savings for bioprocessing industry What does adoption of single-use technology mean for the bioprocessing industry?   The R&D and manufacturing of biologics and biosimilars is extremely expensive due to the amount of detail necessary to replicate and ensure validation of biosynthesis of living cells and their components. It... more ►

June 16, 2016 Promise of genome and cell therapies move closer to reality Stem cell technologies and adoptive immunotherapies are big buzzwords in the cell therapies world, with the promise of personalized therapies driving interest. Boston is a hotbed for cell and gene therapies potential. STATnews reported today that “several Boston-area hospitals have teamed up with... more ►

June 9, 2016 Surviving as a CMO   What are the key factors for survival as a CMO today? Nordic Life Science has spoken to some Nordic CMOs to get an insight into the current possibilities and challenges. Guest post by Anneli Hidalgo, Nordic Life Science   The pharmaceutical sector is undergoing some dramatic changes,... more ►

June 2, 2016 Entrepreneurship, community and serious tax incentives combine to make Puerto Rico an ideal life science hub If you want a lesson in the opportunities available in Puerto Rico, talk to Ignacio Pino. Pino’s company, CDI Laboratories, Inc., a CRO located in Guanajibo Research and Innovation Park in Puerto Rico, is focused on advanced proteomics. “We are a hybrid CRO as we also call ourselves content... more ►

May 19, 2016 How drug development is like your diet If you’re like me, you read the dailies. Companies run the gamut from riding high and plump on investment infusion to rock hard abs times when they’re all muscle and no fat, and, possibly back again. With summer coming, it occurred to me that drug development cycles are very much like dieting,... more ►

partnering360:Insight Latest headlines from partnering360:Insight

June 21, 2016 AZ BioVenture Hub CEO says aim is an innovative ecosystem AstraZeneca’s BioVentureHub CEO explains the exchange's vision to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem. more ►

June 21, 2016 Sixth Element Capital outlines healthcare investment strategy Sixth Element Capital's managing partner explains private UK-based group's healthcare investment thinking. more ►

June 20, 2016 RMI says it has USD 200 million already under management The RusnanoMedInvest fund was set up four years ago and has USD 200 million under management in a ten-year closed end fund financed by Russian institutional investors, with 17 separate investments so far. more ►

June 20, 2016 Achelous Partners is built on knowing both life sciences and finance sectors The European Representative of Achelous Partners says the investment bank's proven strategy and strengths are built on parallel knowledge of the life sciences and financial sectors and outlines recent M&A examples. more ►

June 20, 2016 Seventure Partners targets the microbiome revolution Eric de la Fortelle of Seventure Partners explains the VC's new fund that focuses on the microbiome revolution. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use